Pergolide-induced circling in rats with 6-hydroxydopamine lesions in the nigrostriatal pathway.
In rats with a unilateral 6-hydroxydopamine lesion of the nigrostriatal system we compared the behavioral effects of pergolide with those of L-dopa, bromocriptine, and lergotrile. In this animal model of parkinsonism, doses of 0.25 mg per kilogram pergolide (free base) induced vigorous circling for 24 hours. Pergolide was more potent than bromocriptine or lergotrile. Pretreatment with alpha-methylparatyrosine nearly abolished the effects of bromocriptine, markedly diminished the effects of lergotrile, and only partially diminished the effects of pergolide. These findings suggest that pergolide should be more effective than bromocriptine in the treatment of parkinsonism.
D000818:Animals; D001522:Behavior, Animal / Q000187:drug effects; D001927:Brain Diseases / Q000139:chemically induced; D001971:Bromocriptine / Q000627:therapeutic use; D004873:Ergolines / Q000031:analogs & derivatives / Q000627:therapeutic use*; D005260:Female; D006892:Hydroxydopamines; D016627:Oxidopamine; D010300:Parkinson Disease / Q000188:drug therapy*; D010479:Pergolide; D051381:Rats; D011919:Rats, Inbred Strains
D004873:Ergolines; D006892:Hydroxydopamines; D010479:Pergolide; D001971:Bromocriptine; D016627:Oxidopamine; C031875:lergotrile